Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma

Minimization of Immunosuppressive Therapy Is Associated with Improved Survival of Liver Transplant Patients with Recurrent Hepatocellular Carcinoma

Introduction: Recurrence of hepatocellular carcinoma (rHCC) after liver transplantation (LT) is associated with limited survival. Therefore, identification of factors that prolong survival in these patients is of great interest. Surgical resection, radiotherapy, and transarterial chemoembolization (...

Full description

Bibliographic Details
Main Authors: Ramin Raul Ossami Saidy, Maximilian Paul Postel, Michael Johannes Pflüger, Wenzel Schoening, Robert Öllinger, Safak Gül-Klein, Moritz Schmelzle, Frank Tacke, Johann Pratschke, Dennis Eurich
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
liver transplantation
recurrent hepatocellular carcinoma
immunosuppression
long-term follow-up
surgical tumor resection
Online Access:https://www.mdpi.com/2072-6694/13/7/1617

Internet

https://www.mdpi.com/2072-6694/13/7/1617

Similar Items